The impact of social vulnerability index on survival following autologous stem cell transplant for multiple myeloma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The impact of social vulnerability index on survival following autologous stem cell transplant for multiple myeloma ; day:18 ; month:1 ; year:2024 ; pages:1-7
Bone marrow transplantation ; (18.1.2024), 1-7
- Urheber
-
Salafian, Kiarash
Mazimba, Christine
Volodin, Leonid
Varadarajan, Indumathy
Pilehvari, Asal
You, Wen
Knio, Ziyad O.
Ballen, Karen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41409-024-02200-x
- URN
-
urn:nbn:de:101:1-2024033111245267015597
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Salafian, Kiarash
- Mazimba, Christine
- Volodin, Leonid
- Varadarajan, Indumathy
- Pilehvari, Asal
- You, Wen
- Knio, Ziyad O.
- Ballen, Karen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
Acute kidney injury in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant: a cohort study
Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients
Semi-quantitative FDG parameters predict survival in multiple myeloma patients without autologous stem cell transplantation
Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report
Post-Transplant Maintenance Treatment Options in Multiple Myeloma
Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma
Advancing type 1 diabetes therapy: autologous islet transplant breakthrough
Bloodless tandem autologous transplant in Jehovah’s Witness patients
The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysis
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project
Current status of autologous stem cell transplantation for multiple myeloma
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
Acute kidney injury in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant: a cohort study
Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients
Semi-quantitative FDG parameters predict survival in multiple myeloma patients without autologous stem cell transplantation
Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report
Post-Transplant Maintenance Treatment Options in Multiple Myeloma
Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma
Advancing type 1 diabetes therapy: autologous islet transplant breakthrough
Bloodless tandem autologous transplant in Jehovah’s Witness patients
The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysis
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project
Current status of autologous stem cell transplantation for multiple myeloma
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
Acute kidney injury in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant: a cohort study
Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients
Semi-quantitative FDG parameters predict survival in multiple myeloma patients without autologous stem cell transplantation
Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report
Post-Transplant Maintenance Treatment Options in Multiple Myeloma
Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma
Advancing type 1 diabetes therapy: autologous islet transplant breakthrough
Bloodless tandem autologous transplant in Jehovah’s Witness patients
The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysis
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project